semaglutide drug class A of medications called GLP-1s have skyrocketed in popularity recently for their effectiveness in reducing body mass. The Onion examines the myths and facts surrounding these weight-loss drugs There's still no generic Ozempic,

Acute pancreatitis, gallbladder events, thyroid C-cell concerns (a rat-derived signal that has never been confirmed in humans), and diabetic retinopathy progression in patients with existing retinopathy

These pathways include the cyclic AMP-protein kinase A (cAMP-PKA) pathway, phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling, and nuclear factor kappa B (NF-B)-mediated cascades, which regulate cell proliferation, apoptosis, and migration

J Neurol 2020

What the clinical trial data shows Weight loss SURMOUNT-5 SURMOUNT-5 enrolled 751 adults with obesity but without type 2 diabetes and assigned them to the maximum tolerated dose of either tirzepatide (10 mg or 15 mg) or semaglutide (1.7 mg or 2.4 mg) for 72 weeks

For example, people with problems like scoliosis (curvature of the spine) could have one leg longer than the other

Safety Considerations for Adults with Lymphoproliferative Disorders For adults with existing lymphoproliferative disorders , the decision to initiate or continue GLP-1 agonist therapy requires individualised clinical assessment